IBDEI1LO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28760,2)
 ;;=^270391
 ;;^UTILITY(U,$J,358.3,28761,0)
 ;;=595.89^^181^1833^7
 ;;^UTILITY(U,$J,358.3,28761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28761,1,2,0)
 ;;=2^595.89
 ;;^UTILITY(U,$J,358.3,28761,1,5,0)
 ;;=5^Cystitis Glandularis
 ;;^UTILITY(U,$J,358.3,28761,2)
 ;;=^88153
 ;;^UTILITY(U,$J,358.3,28762,0)
 ;;=595.9^^181^1833^8
 ;;^UTILITY(U,$J,358.3,28762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28762,1,2,0)
 ;;=2^595.9
 ;;^UTILITY(U,$J,358.3,28762,1,5,0)
 ;;=5^Cystitis NOS
 ;;^UTILITY(U,$J,358.3,28762,2)
 ;;=^30304
 ;;^UTILITY(U,$J,358.3,28763,0)
 ;;=V10.51^^181^1833^10
 ;;^UTILITY(U,$J,358.3,28763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28763,1,2,0)
 ;;=2^V10.51
 ;;^UTILITY(U,$J,358.3,28763,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,28763,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,28764,0)
 ;;=V10.59^^181^1833^11
 ;;^UTILITY(U,$J,358.3,28764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28764,1,2,0)
 ;;=2^V10.59
 ;;^UTILITY(U,$J,358.3,28764,1,5,0)
 ;;=5^H/O Urethral Cancer
 ;;^UTILITY(U,$J,358.3,28764,2)
 ;;=^295230
 ;;^UTILITY(U,$J,358.3,28765,0)
 ;;=593.70^^181^1834^46
 ;;^UTILITY(U,$J,358.3,28765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28765,1,2,0)
 ;;=2^593.70
 ;;^UTILITY(U,$J,358.3,28765,1,5,0)
 ;;=5^VUR w/o Nephropathy Unspec
 ;;^UTILITY(U,$J,358.3,28765,2)
 ;;=^303304
 ;;^UTILITY(U,$J,358.3,28766,0)
 ;;=593.71^^181^1834^45
 ;;^UTILITY(U,$J,358.3,28766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28766,1,2,0)
 ;;=2^593.71
 ;;^UTILITY(U,$J,358.3,28766,1,5,0)
 ;;=5^VUR w/ Reflux Nephropathy Unilat
 ;;^UTILITY(U,$J,358.3,28766,2)
 ;;=^303302
 ;;^UTILITY(U,$J,358.3,28767,0)
 ;;=593.72^^181^1834^43
 ;;^UTILITY(U,$J,358.3,28767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28767,1,2,0)
 ;;=2^593.72
 ;;^UTILITY(U,$J,358.3,28767,1,5,0)
 ;;=5^VUR w/ Reflux Nephropathy Bilat
 ;;^UTILITY(U,$J,358.3,28767,2)
 ;;=^303303
 ;;^UTILITY(U,$J,358.3,28768,0)
 ;;=593.73^^181^1834^44
 ;;^UTILITY(U,$J,358.3,28768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28768,1,2,0)
 ;;=2^593.73
 ;;^UTILITY(U,$J,358.3,28768,1,5,0)
 ;;=5^VUR w/ Reflux Nephropathy NOS
 ;;^UTILITY(U,$J,358.3,28768,2)
 ;;=^303305
 ;;^UTILITY(U,$J,358.3,28769,0)
 ;;=403.90^^181^1834^20
 ;;^UTILITY(U,$J,358.3,28769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28769,1,2,0)
 ;;=2^403.90
 ;;^UTILITY(U,$J,358.3,28769,1,5,0)
 ;;=5^HTN Chr Renal Disease,Stages I-IV
 ;;^UTILITY(U,$J,358.3,28769,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,28770,0)
 ;;=403.91^^181^1834^19
 ;;^UTILITY(U,$J,358.3,28770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28770,1,2,0)
 ;;=2^403.91
 ;;^UTILITY(U,$J,358.3,28770,1,5,0)
 ;;=5^HTN Chr Renal Disease Stage V-ESRD
 ;;^UTILITY(U,$J,358.3,28770,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,28771,0)
 ;;=585.9^^181^1834^12
 ;;^UTILITY(U,$J,358.3,28771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28771,1,2,0)
 ;;=2^585.9
 ;;^UTILITY(U,$J,358.3,28771,1,5,0)
 ;;=5^Chr Kidney Disease/Failure
 ;;^UTILITY(U,$J,358.3,28771,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,28772,0)
 ;;=586.^^181^1834^38
 ;;^UTILITY(U,$J,358.3,28772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28772,1,2,0)
 ;;=2^586.
 ;;^UTILITY(U,$J,358.3,28772,1,5,0)
 ;;=5^Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,28772,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,28773,0)
 ;;=584.9^^181^1834^39
 ;;^UTILITY(U,$J,358.3,28773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28773,1,2,0)
 ;;=2^584.9
 ;;^UTILITY(U,$J,358.3,28773,1,5,0)
 ;;=5^Renal Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,28773,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,28774,0)
 ;;=585.1^^181^1834^7
